Adrenocortical carcinoma: presentation and outcome of a contemporary patient series-Reference-Cited by-同舟云学术

Adrenocortical carcinoma: presentation and outcome of a contemporary patient series

Published:2019-04-12 Issue:1 Volume:65 Page:166-174
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Kostiainen Iiro,Hakaste Liisa,Kejo Pekka,Parviainen Helka,Laine Tiina,Löyttyniemi Eliisa,Pennanen Mirkka,Arola Johanna,Haglund Caj,Heiskanen Ilkka,Schalin-Jäntti Camilla^ORCID

Funder

Helsingin ja Uudenmaan Sairaanhoitopiiri

Helsinki University Hospital Research Funds

Finska Läkaresällskapet

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s12020-019-01918-9.pdf

Reference42 articles.

1. T.M. Kerkhofs, R.H. Verhoeven, J.M. Van der Zwan, J. Dieleman, M.N. Kerstens, T.P. Links, L.V. Van de Poll-Franse, H.R. Haak, Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49, 2579–2586 (2013). https://doi.org/10.1016/j.ejca.2013.02.034 .

2. A. Jouinot, J. Bertherat, Management of Endocrine Disease Adrenocortical carcinoma: differentiating the good from the poor prognosis tumors. Eur. J. Endocrinol. 178, R215–R230 (2018). https://doi.org/10.1530/EJE-18-0027

3. M. Fassnacht, S. Johanssen, M. Quinkler, P. Bucsky, H.S. Willenberg, F. Beuschlein, M. Terzolo, H.H. Mueller, S. Hahner, B. Allolio; German Adrenocortical Carcinoma Registry Group, European Network for the Study of Adrenal Tumors, Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer 115, 243–250 (2009). https://doi.org/10.1002/cncr.24030 .

4. G. Assie, G. Antoni, F. Tissier, B. Caillou, G. Abiven, C. Gicquel, S. Leboulleux, J.P. Travagli, C. Dromain, X. Bertagna, J. Bertherat, M. Schlumberger, E. Baudin, Prognostic parameters of metastatic adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 92, 148–154 (2007).

5. E. Kebebew, E. Reiff, Q.Y. Duh, O.H. Clark, A. McMillan, Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J. Surg. 30, 872–878 (2006). https://doi.org/10.1007/s00268-005-0329-x .

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Significance of Hounsfield Unit and Tumor Diameter in the Differentiation of Malignant and Benign Adrenal Masses;Medical Bulletin of Haseki;2024-08-02

2. Results of surgical treatment of adrenocortical cancer;Kazan medical journal;2024-07-25

3. Incidence, Treatment, and Survival of Adrenocortical Carcinoma in Denmark 2003-2019;Journal of the Endocrine Society;2024-01-16

4. Surgical management of metastatic adrenocortical carcinoma;World Journal of Surgery;2023-12-12

5. Case Report: Adrenocortical carcinoma in children—symptoms, diagnosis, and treatment;Frontiers in Endocrinology;2023-11-21